Adjuvant Durvalumab and the Future of Early-Stage NSCLC

Journal of Clinical Oncology (JCO) Podcast by Journals Online Team

Guest Dr. Glenwood Goss and host Dr. Davide Soldato discuss JCO article, " Adjuvant Durvalumab in Completely Resected Early-Stage Non-Small Cell Lung Cancer " and the implications of minimal residual disease, results reg...View more